Not exact matches
Last month, AbbVie reassured investors that Humira would be safe from competition for
at least a
few more years, granting rival Amgen Inc (AMGN.O) a non-exclusive license to sell a copycat version in the United States, but not
before 2023.
Hopefully though I'm learning what I like and don't like
before I shell out the money (well,
at least a little
more than a
few years ago!).
I want to be agented (dream agent: Amy Boggs with the Donald Maass Literary agency), I want to enter a
few writing contests, I want to have
at least two stories drafted and fully polished (though partially will work too), AND, this is a new goal we each decided upon
before leaving, I want to attend another Deep Immersion Master Class next
year (yup, we're going back together next
year for
more!).
We may not know the entire roster
before launch, but we'll probably get
at least a
few more before the end of the
year, including a rumored announcement
at the Capcom Cup Finals.